Free Trial
ASX:IXC

Invex Therapeutics (IXC) Stock Price, News & Analysis

About Invex Therapeutics Stock (ASX:IXC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
A$5.64 million
P/E Ratio
N/A
Dividend Yield
230.00%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Invex Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

IXC Stock News Headlines

This Cold War “Accident” Could Unleash New $100 Trillion AI Boom
Obscure Metal More Valuable than Gold and Bitcoin… COMBINED? This strange "AI Metal" holds the key to the $100 trillion AI boom. Which is why Jeff Brown recently traveled to a location that has one of the highest concentrations of this metal in the world. And you won't believe what he uncovered.
See More Headlines

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
ASX:IXC
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.02)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$1.64 million
Net Margins
-135.43%
Pretax Margin
N/A
Return on Equity
-29.89%
Return on Assets
-9.22%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.18
Quick Ratio
29.36

Sales & Book Value

Annual Sales
A$1.21 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
A$0.08 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
75,150,000
Free Float
N/A
Market Cap
A$5.64 million
Optionable
Not Optionable
Beta
0.47
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (ASX:IXC) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners